310 related articles for article (PubMed ID: 10590894)
1. Treatment of immune-mediated inflammatory neuropathies.
Hadden RD; Hughes RA
Curr Opin Neurol; 1999 Oct; 12(5):573-9. PubMed ID: 10590894
[TBL] [Abstract][Full Text] [Related]
2. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
Radziwill AJ; Kuntzer T; Steck AJ
Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
[TBL] [Abstract][Full Text] [Related]
3. Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Lindenbaum Y; Kissel JT; Mendell JR
Neurol Clin; 2001 Feb; 19(1):187-204. PubMed ID: 11471764
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Guillain-Barré syndrome and CIDP.
van Doorn PA
J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
[TBL] [Abstract][Full Text] [Related]
5. Immune-mediated neuropathies.
Kieseier BC; Mathey EK; Sommer C; Hartung HP
Nat Rev Dis Primers; 2018 Oct; 4(1):31. PubMed ID: 30310069
[TBL] [Abstract][Full Text] [Related]
6. Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.
Dziadkowiak E; Nowakowska-Kotas M; Rałowska-Gmoch W; Budrewicz S; Koszewicz M
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298132
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
Sederholm BH
Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
[TBL] [Abstract][Full Text] [Related]
8. Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Querol L; Lleixà C
Neurotherapeutics; 2021 Oct; 18(4):2222-2235. PubMed ID: 34549385
[TBL] [Abstract][Full Text] [Related]
9. Treatment of dys-immune neuropathies.
Nobile-Orazio E
J Neurol; 2005 Apr; 252(4):385-95. PubMed ID: 15834625
[TBL] [Abstract][Full Text] [Related]
10. Treatment of immune neuropathies.
Van Doorn PA; Garssen MP
Curr Opin Neurol; 2002 Oct; 15(5):623-31. PubMed ID: 12352007
[TBL] [Abstract][Full Text] [Related]
11. Management of inflammatory neuropathies.
Hadden RD; Hughes RA
J Neurol Neurosurg Psychiatry; 2003 Jun; 74 Suppl 2(Suppl 2):ii9-ii14. PubMed ID: 12754323
[No Abstract] [Full Text] [Related]
12. Current treatment of neuromuscular diseases.
Kokontis L; Gutmann L
Arch Neurol; 2000 Jul; 57(7):939-43. PubMed ID: 10891975
[No Abstract] [Full Text] [Related]
13. [Acute and chronic inflammatory neuropathies--therapy].
Köller H; Kieseier BC; Jander S; Hartung HP
Dtsch Med Wochenschr; 2003 Jun; 128(25-26):1405-7. PubMed ID: 12813675
[No Abstract] [Full Text] [Related]
14. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
Eldar AH; Chapman J
Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
[TBL] [Abstract][Full Text] [Related]
15. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
16. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
Busby M; Donaghy M
J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
[TBL] [Abstract][Full Text] [Related]
17. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
Mathis S; Vallat JM; Magy L
Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
[TBL] [Abstract][Full Text] [Related]
18. [Clinical guideline review: Guillain-barre syndrome and chronic inflammatory demyelinating polyneuropathy].
Mori K; Hattori N; Sobue G
Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2443-57. PubMed ID: 12373856
[No Abstract] [Full Text] [Related]
19. Acquired inflammatory demyelinating neuropathies.
Ensrud ER; Krivickas LS
Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
[TBL] [Abstract][Full Text] [Related]
20. Plasma exchange in immune-mediated neuropathies.
Lehmann HC; Hartung HP; Meyer Zu Hörste G; Kieseier BC
Curr Opin Neurol; 2008 Oct; 21(5):547-54. PubMed ID: 18769248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
